Executive Summary
Across 50 Q3 2026 filings, revenue growth was solid but highly uneven: 32 companies grew revenue YoY (median +8.9%), while 18 posted declines or zero revenue, and margin compression was the dominant theme—over half of reporting companies cited rising costs outpacing revenue.
Energy and aerospace led absolute growth (ExxonMobil revenue +32.6%, FTAI Aviation +46.6%), while healthcare REITs, banks, and consumer discretionary names faced margin pressure and credit provisions. A striking pattern was the prevalence of one-time items distorting headline earnings: real estate gains (Alexander's $148M, Centerspace $150.3M), debt extinguishment losses (Herbalife $94.6M), and investment losses (IAC $1.12B MGM write-down) made GAAP results noisy. Insider activity was sparse but notable where present: W.R. Berkley accelerated buybacks to $435.1M (vs $73.8M), Marriott repurchased $3.08B YTD, and several companies raised dividends (Northwest Pipeline +5%). Forward-looking signals were mixed: V2X remaining performance obligations grew 14.7% to $3.87B, IDEXX and Roku showed strong organic momentum, but CNA Financial and Loews suffered large insurance re-measurement losses and unrealized investment losses, flagging rate sensitivity. Overall, the quarter favored companies with pricing power and clean operational execution, while those with credit, rate, or cost exposure lagged.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 10-Q
Tracking the trend? Catch up on the prior US Earnings Financial Results SEC Filings digest from October 30, 2026.
Investment Signals (12)
- ExxonMobil (XOM) (BULLISH)▲
Q3 2026 net income doubled YoY to $15.4B on revenue +32.6%, with Upstream and Energy Products each contributing >$7B; nine-month EPS $8.18 vs $5.16
- IDEXX Laboratories (IDXX) (BULLISH)▲
Revenue +9.9% YoY, EPS +17.9% to $4.01, operating cash flow up 28.7% to $1.06B; CAG consumables +14.3% and reference lab +10.0% show durable companion-animal demand
- Roku (ROKU) (BULLISH)▲
Revenue +24.1% YoY to $1.50B, net income surged to $183.3M from $24.8M, operating income positive at $164.1M; Platform advertising +23% and subscriptions +22.7%
- Marriott (MAR) (BULLISH)▲
Q3 EPS +13.9% to $3.04 on revenue +8.0%, franchise fees +15.0% and incentive fees +22.3%; $3.08B YTD buybacks reduced share count 4.1%
- BWX Technologies (BWXT) (BULLISH)▲
Revenue +10.0% YoY, EPS +24.7% to $1.11, nine-month revenue +17.4%; interest expense down 63.6% YoY
- ON Semiconductor (ON) (BULLISH)▲
Revenue +11.1% YoY, EPS +25.4% to $0.79, gross profit +21.4% driven by PSG segment (+61.6% gross profit); cash rose to $4.16B from $2.15B
- Krystal Biotech (KRYS) (BULLISH)▲
Product revenue +30.2% YoY to $127.3M, international expansion (Europe $23.3M vs $4.9M, Japan $8.8M vs nil), operating income +72% to $71.1M
- Tempus AI (TEM) (BULLISH)▲
Revenue +23.1% YoY to $411.5M, net loss narrowed to $14.9M from $80.0M; Data & applications revenue +32.9%
- Syndax Pharmaceuticals (SNDX) (BULLISH)▲
Total revenue +81.6% YoY to $83.3M, product revenue +89.8%; net loss narrowed to $49.4M from $60.7M
- First Bancorp (FBNC) (BULLISH)▲
Q3 net income +152% YoY to $51.3M, EPS $1.24 vs $0.49; net interest income +12% and provision fell to $1.3M from $3.4M
- Shore Bancshares (SHBI) (BULLISH)▲
Net income +16.9% YoY, EPS $0.50 vs $0.43; net interest income +13.9% as interest expense fell 12.7%
- Backblaze (BLZE) (BULLISH)▲
Revenue +25.5% YoY, gross margin improved to 64.0% from 62.1%, net loss narrowed to $2.36M from $3.78M; $201M convertible notes bolster balance sheet
Risk Flags (10)
- CNA Financial (CNA) [HIGH RISK]▼
Q3 net income plunged 51% YoY to $196M as insurance claims rose 15.5% including a $222M re-measurement loss; comprehensive income swung to a $837M loss on $1.84B unrealized investment losses
- Loews (L) [HIGH RISK]▼
Net income down 39% YoY to $306M on same $222M insurance re-measurement loss; $2.08B unrealized investment loss drove comprehensive loss of $636M vs income of $845M
- First Hawaiian (FHB) [HIGH RISK]▼
Net income -13.7% YoY to $63.7M as provision jumped to $20.3M from $4.5M and noninterest expense surged 27.3%; comprehensive income collapsed to $19.7M from $92.7M
- First Interstate BancSystem (FIBK) [HIGH RISK]▼
Q3 net income -12.9% YoY, provision $10.5M vs $0, loans -8.0% YoY, AOCI loss widened to $314.1M; comprehensive loss of $48.4M vs income of $100.2M
- Diversified Healthcare Trust (DHC)↓ [HIGH RISK]▼
Revenue -5.4% YoY, rental income -13.7%; net loss $50.2M though narrower; total assets and equity declined; disposition proceeds fell to $21.7M from $349.4M
- Onex Direct Lending BDC (OXLC-like) [HIGH RISK]▼
Total investment income -41% YoY, net investment income -45%, net realized losses of $17.7M in Q3; NAV per share fell to $17.04 from $20.81
- i-80 Gold (IAU)↓ [HIGH RISK]▼
Net loss widened to $48.4M from $41.9M despite flat revenue; cash used in operations deepened to $127.2M from $49.3M; total liabilities more than doubled to $931.1M
- Sinda Ltd. (SNDA)↓ [HIGH RISK]▼
Net loss widened 5.4x to $14.9M; exploration expenses surged to $10.1M from $1.3M; operating cash burn $33.2M vs $7.7M
- Herbalife (HLF) [HIGH RISK]▼
Nine-month net income fell 33.9% to $94.4M due to $94.6M debt extinguishment loss; China segment -22% YoY; gross margin slipped to 77.3%
- Choice Hotels (CHH) [HIGH RISK]▼
Net income plunged 67.8% YoY to $57.9M on $24.3M contract termination costs and $6.0M impairment; prior year included $100M JV gain
Opportunities (10)
- FTAI Aviation (FTAI) (OPPORTUNITY)◆
Revenue +46.6% YoY to $977.7M, aerospace products +70%, MRE contract revenue +120.6%; net income +27.9% to $150.6M despite inventory build; potential margin recovery as inventory converts to sales
- Nextpower (NXT) (OPPORTUNITY)◆
Revenue +22.5% YoY, EPS $1.08 vs $0.97; R&D investment +69.5% signals new product cycle; repurchased 1.8M shares for $162.1M
- V2X (VVX) (OPPORTUNITY)◆
Revenue +8.9% YoY, remaining performance obligations +14.7% to $3.87B; US revenue +30.6% and time-and-materials +470% show mix shift
- Waystar (WAY) (OPPORTUNITY)◆
Revenue +21.2% YoY to $325.6M; operating expenses surged but net income held at $31.0M; potential operating leverage as G&A and R&D investments mature
- Centerspace (CSR)↓ (OPPORTUNITY)◆
Net income surged to $143.6M on $150.3M real estate gain; fully repaid $154.9M revolving credit; strong balance sheet for acquisitions
- Alexander's (ALX) (OPPORTUNITY)◆
Q3 EPS $5.33 vs $1.16 on $148M real estate gain; rental revenues +34.9% YoY; interest expense declined
- SITE Centers (SITC) (OPPORTUNITY)◆
Debt fully repaid, interest expense zero vs $3.9M; cash from asset sales provides flexibility for reinvestment or special dividend
- Miami International Holdings (MIAX) (OPPORTUNITY)◆
Net income $52.5M vs loss; nine-month net income $266.9M aided by $50.6M gain on sale and $74M tax benefit; operating cash flow up 71% to $206.7M
- Estée Lauder (EL) (OPPORTUNITY)◆
Q1 FY2027 net sales +6.7% YoY, operating income more than doubled to $408M, EPS $0.64 vs $0.13; gross margin improved to 75.7%
- Vornado Realty (VNO) (OPPORTUNITY)◆
Q3 revenue +3.1% YoY, rental revenues +5.3%; net loss due to depreciation and lower investment income, but NYC office recovery could drive upside
Sector Themes (6)
- Margin Compression Despite Revenue Growth◆
18 of 32 revenue-growing companies reported gross or operating margin declines, with cost of sales rising faster than revenue (e.g., Nextpower gross margin -130 bps, FTAI cost of sales +82%, ON Semiconductor mixed segment performance). Companies investing heavily in R&D (Nextpower +69.5%, Waystar +63.7%) face near-term margin pressure but potential long-term payoff.
- Insurance Sector Hit by Re-measurement and Investment Losses◆
CNA Financial and Loews both reported $222M insurance re-measurement losses and large unrealized investment losses ($1.84B and $2.08B respectively), driving comprehensive losses. W.R. Berkley also swung to investment losses ($18.3M vs $79M gain) and AOCI loss widened to $1.25B. Rising rates are pressuring investment portfolios across insurers.
- Real Estate Asset Sales Distort Earnings◆
Alexander's ($148M gain), Centerspace ($150.3M gain), SITE Centers (portfolio shrinkage), and Sabra (loan loss provision) highlight active portfolio repositioning. Excluding one-time gains, underlying earnings were mixed, with REITs facing higher interest expense and impairment charges.
- Healthcare Innovation Drives Outperformance◆
IDEXX (+9.9% revenue, +17.9% EPS), Krystal Biotech (+30.2% revenue), Tempus AI (+23.1% revenue), and Syndax (+81.6% revenue) all posted strong top-line growth, benefiting from diagnostics, gene therapy, and precision medicine demand. However, profitability varied widely, with Tempus and Syndax still loss-making.
- Banking Sector Credit Provisions Rise◆
First Hawaiian ($20.3M vs $4.5M), First Interstate ($10.5M vs $0), and Shore Bancshares ($5.3M, +76.1%) all reported increased provisions, signaling deteriorating credit quality or conservative builds. Net interest income was mixed, with some banks benefiting from lower deposit costs (First Bancorp +12%, Shore +13.9%) while others saw loan yields compress.
- Energy and Industrials Capitalize on Pricing◆
ExxonMobil (+32.6% revenue), FTAI Aviation (+46.6%), and BWX Technologies (+10.0%) demonstrated pricing power and volume growth. However, FTAI's negative operating cash flow (-$333M) due to inventory build and Exxon's lower equity affiliate income (-11.1%) show operational challenges beneath the surface.
Watch List (8)
- CNA Financial (CNA)👁
Q3 net income -51% YoY, re-measurement loss $222M; watch for further reserve adjustments and investment portfolio impact from rising rates; next earnings call likely early February 2027
- Loews (L)👁
Similar insurance headwinds; comprehensive loss $636M; watch for capital allocation decisions and potential buybacks amid depressed valuation
- First Hawaiian (FHB)👁
Provision jump and expense surge; merger-related costs $6.7M; watch for integration progress and credit trends; next earnings call late January 2027
- FTAI Aviation (FTAI)👁
Inventory build $885.9M and negative operating cash flow; watch for conversion to sales and margin recovery in Q4 2026
-
Cash surge to $411.4M from financings, but operating cash burn $127.2M; watch for project development milestones and potential dilution
-
Cash $305.6M from share issuance, but losses widening; watch for exploration results and cash burn rate
- Herbalife (HLF)👁
China weakness and debt extinguishment loss; watch for restructuring progress and margin trends; next earnings call February 2027
- Choice Hotels (CHH)👁
Contract termination costs and impairment; watch for RevPAR trends and pipeline growth; next earnings call February 2027
Filing Analyses
(50)
02-11-2026
Indigo Acquisition Corp. reported Q3 2026 net income of $950,826, down 6.2% from $1,013,198 in Q3 2025, while nine-month net income surged 237% YoY to $2,751,952 from $815,689 on higher trust account dividend income ($3,174,275 vs $1,165,212). However, formation and operating costs rose 75% for the nine-month period to $422,323 from $241,360, and cash fell to $188,753 from $666,920 at year-end 2025. The SPAC holds $120,472,646 in its trust account, up from $117,298,371 at December 31, 2025, with 11,500,000 redeemable shares at a $10.48 redemption value.
- · Redemption value per share rose to $10.48 at September 30, 2026 from $10.20 at December 31, 2025
- · Basic and diluted net income per redeemable share was $0.06 in Q3 2026 vs $0.07 in Q3 2025
- · Nine-month diluted EPS was $0.19 in 2026 vs $0.12 in 2025
- · Remeasurement of ordinary shares to redemption value totaled $3,174,275 for nine months 2026
- · Total shareholders' deficit widened to $3,745,774 from $3,323,451 at December 31, 2025
- · No preference shares issued or outstanding; 20,000,000 authorized
- · Deferred underwriting fee payable held flat at $4,025,000
- · Nine-month 2025 financing activities generated $116,142,895 including $112,700,000 from unit sales and $3,800,000 from private placement units
02-11-2026
Diversified Healthcare Trust reported Q3 2026 total revenues of $367.67M, down 5.4% YoY from $388.71M, as rental income fell 13.7% to $47.75M and residents fees and services declined 4.0% to $319.92M. The net loss narrowed sharply to $50.23M (loss of $0.21/share) from $164.04M ($0.68/share) a year earlier, helped by a much smaller impairment charge ($14.54M vs $93.24M) and lower interest expense ($37.16M vs $48.89M). However, general and administrative costs rose 14.5% to $14.64M and acquisition/transaction costs jumped to $3.30M from $1.16M, while the company posted a $0.89M loss on real estate sales versus a $1.26M gain last year.
- · Nine-month 2026 net cash provided by operating activities surged to $74.12M from just $0.49M in 2025.
- · Nine-month 2026 proceeds from real estate sales fell to $21.69M from $349.38M a year earlier, reflecting a much smaller disposition program.
- · Total assets declined to $4.19B at September 30, 2026 from $4.36B at December 31, 2025; total shareholders' equity fell to $1.53B from $1.67B.
- · In March 2026 the company sold 13 senior living (SHOP) properties totaling 669 units for $23.00M, recording a $1.21M loss on sale.
- · Nine-month 2026 impairment of assets was $14.54M versus $162.71M in 2025.
- · Nine-month 2026 loss on sale of real estate was $2.73M versus a $103.97M gain in 2025.
- · Senior unsecured notes, net stood at $1.58B and senior secured notes, net at $366.52M as of September 30, 2026.
- · Nine-month 2026 distributions to shareholders were $7.26M versus $7.24M in 2025.
02-11-2026
IDEXX reported Q3 2026 revenue of $1,214,237 thousand, up 9.9% YoY from $1,105,239 thousand, with net income rising 15.5% to $317,145 thousand and diluted EPS up 17.9% to $4.01. CAG segment revenue grew 10.2% to $1,115,968 thousand, driven by IDEXX VetLab consumables (+14.3%) and reference lab services (+10.0%), while CAG Diagnostics capital instruments were flat at $51,492 thousand. However, gross margin compressed to 62.9% from 61.8% prior year on higher cost of service revenue, and general and administrative expenses jumped 16.4% YoY, outpacing revenue growth.
- · Gross margin improved to 62.9% from 61.8% YoY despite higher cost of service revenue
- · Nine-month operating cash flow rose to $1,063,127 thousand from $826,045 thousand
- · Goodwill increased to $640,506 thousand from $414,004 thousand at Dec 31, 2025, reflecting a $223,430 thousand business acquisition
- · Company repurchased $810,014 thousand of stock over nine months, reducing shares outstanding to 78,790 thousand
- · CAG Diagnostics capital instruments revenue was flat YoY at $51,492 thousand
- · LPD segment grew only 2.6% YoY, the slowest of the reporting segments
- · Foreign currency translation swung to a $13,928 thousand loss from a $58,434 thousand gain in the prior-year period
- · Diluted weighted average shares fell to 79,049 thousand from 80,675 thousand
02-11-2026
FTAI Aviation reported Q3 2026 total revenues of $977.7M, up 46.6% YoY from $667.1M, driven by aerospace products revenue nearly doubling (+70.0% to $780.6M) and MRE contract revenue more than doubling (+120.6% to $129.4M). However, legacy leasing-related lines declined sharply: lease income fell 54.1% to $25.3M, maintenance revenue dropped 47.9% to $27.3M, and asset sales revenue plunged 84.7% to $5.9M. Net income rose 27.9% to $150.6M and diluted EPS improved to $1.43 from $1.10, while operating cash flow turned negative at -$333.0M versus -$131.7M a year ago, largely on an $885.9M inventory build.
- · Nine-month net income grew only 7.3% YoY to $413.6M despite 49.6% revenue growth, reflecting margin compression from cost of sales rising to $1.784B from $980.9M.
- · Operating cash flow deteriorated to -$333.0M for 9M 2026 from -$131.7M, driven by an $885.9M inventory build versus $391.9M a year earlier.
- · Inventory rose 61.8% to $1.932B from $1.194B at year-end 2025, while leasing equipment fell 33.0% to $1.035B from $1.546B.
- · Research and development expense of $22.0M in Q3 2026 and $41.5M for 9M 2026 versus zero in the prior-year periods.
- · Depreciation and amortization declined to $43.3M in Q3 2026 from $55.3M, and to $142.6M for 9M from $170.1M.
- · Interest expense rose to $65.1M in Q3 2026 from $60.8M, with long-term debt roughly flat at $3.456B.
- · Equity in earnings of unconsolidated entities swung to +$16.9M in Q3 2026 from -$4.2M a year ago.
- · Company repurchased $50.0M of shares in Q3 2026 and redeemed $105.5M of preferred shares during 9M 2026.
- · Contract liabilities - affiliate of $234.0M appeared on the balance sheet as of September 30, 2026 (none at year-end 2025).
- · Gain on sale to the 2025 Partnership - affiliate fell to $17.6M for 9M 2026 from $50.1M a year earlier.
02-11-2026
CNA Financial reported Q3 2026 net income of $196M, down 51% YoY from $403M, with diluted EPS falling to $0.72 from $1.48, driven by a sharp rise in insurance claims and policyholders' benefits (+15.5% to $2,347M, including a $222M re-measurement loss vs $36M prior year). Total revenues were essentially flat at $3,821M (+0.1% YoY) as net earned premiums grew 1.7% to $2,831M but non-insurance warranty revenue declined 9.2% to $357M. Nine-month net income fell 25% to $728M and total comprehensive income swung to a $837M quarterly loss from $778M income, reflecting $1,844M of unrealized investment losses amid rising rates.
- · Accumulated other comprehensive loss widened to $2,249M from $1,098M at year-end 2025
- · Total stockholders' equity fell to $10,229M from $11,621M at December 31, 2025
- · Net cash from operating activities declined to $1,696M from $1,920M for nine months
- · Short-term debt of $499M added while long-term debt fell to $2,475M from $2,971M
- · Quarterly dividend raised to $0.48 per share from $0.46
- · Fixed maturity securities fair value of $42,067M vs amortized cost of $46,013M, reflecting unrealized losses
- · Income before income tax fell to $237M from $513M in Q3
02-11-2026
MineralRite reported Q3 2026 net income of $358,577 versus $24,588 in Q3 2025, but the profit was entirely driven by a one-time $507,442 gain on disposition of fixed, terminating royalty interests — with zero revenue in both periods. Year-to-date net income was only $4,804 versus a $125,548 loss in 2025, while operating expenses more than doubled to $464,068 from $235,908. Net loss attributable to common shareholders was $(8,384,290) for Q3 2026 due to an $8,740,242 excess of Series NMC Preferred repurchase price over par, and cash fell to $7,617 from $11,617 at year-end 2025.
- · Revenue was $0 in both Q3 2026 and Q3 2025 — the company generated no mineral sales or services income.
- · Legal and professional fees rose to $94,300 in Q3 2026 from $45,600 a year earlier, and to $289,900 for nine months versus $136,800.
- · Office & insurance expense jumped to $35,122 in Q3 2026 from $13,503.
- · Project development costs of $36,971 were incurred in nine-month 2026 versus $0 in 2025.
- · Prepaid services of $134,363 at 12/31/2025 were fully drawn down to $0 by 9/30/2026.
- · Mineral royalties of $1,380,000 at 12/31/2025 were eliminated to $0 by 9/30/2026 following the royalty disposition.
- · Investments declined to $20,925 from $51,300, with a $30,375 unrealized loss recorded in nine-month 2026.
- · Accounts payable increased to $120,434 from $48,948, and notes payable rose to $41,920 from $15,520.
- · A new MAG payable (ASLD deferral) of $99,414 appeared on the balance sheet.
- · Nine-month 2026 operating cash burn was $195,450, improved from $247,467 in 2025.
- · Earnings per share attributable to common was $(0.001342) in Q3 2026 versus $0.000005 in Q3 2025.
- · The Restated Certificate of Formation was approved by shareholders on September 28, 2026 but had not been processed by the Texas Secretary of State as of the report date.
02-11-2026
ExxonMobil Holdings Corp reported Q3 2026 net income attributable to ExxonMobil of $15,413M, up 104% YoY from $7,548M, on revenue of $110,503M (+32.6% YoY). Nine-month net income rose 52.7% to $34,121M and diluted EPS jumped to $8.18 from $5.16. However, income from equity affiliates declined 11.1% YoY in Q3 and 17.3% over nine months, and other comprehensive income swung to a $727M loss for nine months versus a $2,036M gain in 2025, driven by foreign exchange translation losses.
- · Upstream segment income was $7,088M in Q3 2026 ($3,201M U.S. + $3,887M non-U.S.), the largest contributor to segment income of $16,277M.
- · Energy Products segment income was $7,169M ($4,787M U.S. + $2,382M non-U.S.); Chemical Products $735M; Specialty Products $1,285M.
- · Corporate and Financing recorded a loss of $864M in Q3 2026.
- · Nine-month 2026 capex was $20,175M, down slightly from $20,908M in 2025.
- · Nine-month 2026 buybacks of $15,110M were up from $14,894M in 2025; dividends of $12,897M were roughly flat vs $12,865M.
- · Cash and cash equivalents rose to $12,153M at September 30, 2026 from $10,681M at December 31, 2025.
- · Notes and accounts receivable jumped to $66,533M from $44,562M, and accounts payable rose to $78,642M from $60,911M.
- · A redomicile transaction reduced common stock by $1,846M and earnings reinvested by $266,430M, offset by a $268,276M treasury stock adjustment.
- · Nine-month 2026 depreciation and depletion rose to $22,263M from $18,278M, including impairments.
- · Q3 2026 exploration expenses fell to $116M from $149M; 2025 included a $40M exploratory well write-off.
- · Nine-month 2026 foreign exchange translation adjustment was a $536M loss versus a $2,047M gain in 2025.
02-11-2026
Williams Companies (parent of Northwest Pipeline LLC) reported Q3 2026 total revenues of $3,223M, up 10.3% YoY from $2,923M, and nine-month revenues of $9,306M, up 6.3% YoY. Net income available to common stockholders rose 8.2% YoY to $699M in Q3 and 27.0% to $2,390M for nine months, aided by $277M of asset sale gains and $188M of other investing income. However, NWP segment results weakened: Q3 revenues were essentially flat at $840M (vs $844M) and NWP operating income fell 11.8% YoY to $419M, while net gain from commodity derivatives swung to a $263M nine-month loss from a $30M gain, and G&A expenses jumped 63.7% YoY in Q3.
- · Q3 2026 basic EPS was $0.56 vs $0.53 in Q3 2025; nine-month EPS $1.95 vs $1.54
- · Q3 2026 common dividend raised to $0.525 per share from $0.500 per share
- · NWP Q3 2026 depreciation and amortization rose to $148M from $111M YoY
- · NWP Q3 2026 general and administrative expenses (affiliates) rose to $52M from $45M
- · NWP third-party natural gas transportation revenues declined to $716M from $731M YoY
- · Nine-month 2026 operating cash flow was $4,484M vs $4,322M in 2025
- · Total assets grew to $70,680M from $58,573M at December 31, 2025
- · Noncontrolling interests rose to $5,761M from $2,188M, reflecting the partial subsidiary sale
- · Nine-month 2026 net cash used in investing was $7,998M vs $3,202M in 2025
02-11-2026
Onex Direct Lending BDC Fund reported a sharp deterioration in Q3 2026, with total investment income falling 41% YoY to $7.22M from $12.30M and net investment income dropping 45% to $3.58M from $6.49M. Net realized losses on investments of $17.67M (versus a $0.69M gain in Q3 2025) drove a $31.95M realized loss for the nine-month period, though a $16.10M unrealized appreciation in Q3 partially offset this, yielding a modest $2.02M net increase in net assets from operations versus a $4.05M decrease a year earlier. Net assets shrank to $136.62M from $194.10M at year-end 2025, NAV per share declined to $17.04 from $20.81, and shares outstanding fell to 8,019,722 from 9,326,142 amid continued redemptions.
- · Q3 2026 interest income fell to $6,781,077 from $11,645,167 in Q3 2025 (-41.8%).
- · Nine-month 2026 interest income was $23,380,052 versus $36,566,950 in 2025 (-36.1%).
- · Q3 2026 interest and credit facility expense was $2,521,736 versus $4,352,717 in Q3 2025.
- · Nine-month 2026 net realized losses of $56,014,852 contrast with a $522,269 gain in 2025.
- · Accumulated distributable losses widened to $78,007,394 from $45,360,681 at year-end 2025.
- · Redemptions of 421,913 shares for $7,303,314 occurred in Q3 2026; 1,331,738 shares for $25,323,126 over nine months.
- · Nine-month 2026 purchases and drawdowns of investments were $41,885,591 versus $189,956,959 in 2025, while sales and repayments were $146,873,808 versus $281,897,407.
- · Level 3 investments totaled $206,756,210 at September 30, 2026, with net change in unrealized depreciation on still-held Level 3 investments of $(7,937,444).
- · Non-cash restructuring of portfolio investment was $15,403,109 for nine months 2026.
- · Cash and cash equivalents plus restricted cash ended at $8,341,216 versus $9,978,386 a year earlier.
- · No incentive fee was recorded in Q3 2026 or Q3 2025; nine-month 2025 incentive fee was $878,959.
02-11-2026
Sabra Health Care REIT reported Q3 2026 total revenues of $249.6M, up 31.3% YoY from $190.0M, driven by resident fees and services (+55.6% to $143.2M) and rental revenues (+20.9% to $103.2M). However, nine-month net income attributable to Sabra fell 65.5% to $44.3M from $128.4M, largely due to a $104.6M provision for loan losses versus a $0.6M recovery a year earlier, and interest and other income declined 25.0% YoY in Q3. Diluted EPS was $0.11 for Q3 2026 versus $0.09 a year ago, while nine-month diluted EPS dropped to $0.17 from $0.53.
- · Total assets declined to $5.43B at September 30, 2026 from $5.49B at December 31, 2025.
- · Loans receivable and other investments fell to $120.3M from $434.1M, reflecting $210.7M of repayments during the nine months.
- · Revolving credit facility balance reduced to $126.5M from $217.6M at year-end 2025.
- · Nine-month 2026 acquisitions of real estate totaled $511.4M in total consideration versus $283.1M a year earlier.
- · Net gain on sales of real estate was $29.7M for nine months 2026 versus $5.5M in 2025.
- · Q3 2026 net loss on sales of real estate was $8.1M.
- · Senior housing operating portfolio operating expenses rose 50.6% YoY in Q3 to $99.3M.
- · General and administrative expenses increased 24.1% YoY in Q3 to $15.6M.
- · Cash and cash equivalents dropped to $36.2M from $71.5M at December 31, 2025.
- · Common dividends of $0.30 per share were paid in Q3 2026, totaling $77.7M.
02-11-2026
Tactile Systems Technology reported Q3 2026 total revenue of $91.858M, up 7.1% YoY from $85.755M, driven by sales revenue growth of 7.1% to $82.329M and rental revenue growth of 7.5% to $9.529M. However, operating income declined 12.5% YoY to $9.591M and net income fell 12.8% to $7.160M, with diluted EPS down to $0.31 from $0.36, as operating expenses rose 12.7% to $60.898M. On a nine-month basis, net income rose 56.0% to $13.182M and diluted EPS increased to $0.57 from $0.36, while cash declined $8.336M to $75.110M due to $12.528M in share repurchases and $6.226M acquisition payments.
- · Sales and marketing expense rose 10.8% YoY to $33.042M in Q3 2026 from $29.809M
- · Research and development expense rose 14.4% YoY to $2.506M from $2.191M
- · Reimbursement, general and administrative expense rose 15.0% YoY to $24.657M from $21.442M
- · Nine-month 2026 total revenue was $252.823M vs $225.928M in 2025 (+11.9%)
- · Cash paid for taxes increased to $5.238M in nine-month 2026 from $0.899M in 2025
- · Goodwill increased $8.491M to $39.554M due to an acquisition
- · Intangible assets rose to $43.721M from $39.167M at year-end 2025
- · Accounts payable increased to $11.792M from $4.968M at December 31, 2025
- · Total stockholders' equity increased to $227.252M from $218.902M at December 31, 2025
02-11-2026
Rithm Capital reported Q3 2026 net income of $261.3M, up 14% YoY from $228.8M, driven by servicing revenue net nearly doubling to $716.6M (from $314.9M) and a $121.3M positive MSR fair value change versus a $264.4M loss a year ago, plus new commercial real estate revenue of $187.0M. However, nine-month net income fell 30% YoY to $438.7M from $627.5M, income tax expense surged to $257.8M in Q3 (from $8.1M), and total expenses jumped 36% to $1,276.5M, pressuring margins despite the quarterly improvement.
- · Nine-month diluted EPS fell to $0.54 from $0.95 YoY
- · Nine-month net income attributable to common stockholders declined 40.6% to $305.2M from $514.1M
- · Income tax expense of $257.8M in Q3 2026 versus $8.1M in Q3 2025
- · Depreciation and amortization rose to $92.4M in Q3 2026 from $23.1M
- · Compensation and benefits rose 27.9% YoY to $382.4M in Q3 2026
- · Accumulated deficit widened to $(154.5)M from $(19.9)M at year-end 2025
- · Preferred dividends rose to $36.2M in Q3 2026 from $27.9M
- · Mortgage servicing rights grew to $12.2B from $10.4B at Dec 31, 2025
- · Net cash used in operating activities was $1.31B for nine months 2026
- · Dividends declared per common share held flat at $0.25 quarterly / $0.75 nine-month
02-11-2026
Nextpower Inc. reported Q2 FY2027 revenue of $1,109.3M, up 22.5% YoY from $905.3M, with net income rising 12.7% to $165.5M and diluted EPS of $1.08 versus $0.97. However, gross margin compressed to 31.1% from 32.4% as cost of sales grew 24.8%, faster than revenue, and R&D spending jumped 69.5% to $45.6M, weighing on operating margin (18.7% vs 20.0%). For the six-month period, revenue rose 15.5% to $2,044.4M and net income grew 8.8% to $330.8M, while the company repurchased 1.8M shares for $162.1M and goodwill rose to $653.6M from $489.0M, signaling acquisition activity.
- · Gross margin fell to 31.1% in Q2 FY2027 from 32.4% a year earlier as cost of sales rose 24.8% to $764.0M, outpacing 22.5% revenue growth
- · Operating income grew only 14.4% YoY to $207.5M, lagging revenue growth, with operating margin down to 18.7% from 20.0%
- · R&D expense surged 69.5% YoY to $45.6M in Q2 and 86.0% to $90.1M for the six months, reflecting heavy investment
- · Six-month net income growth of 8.8% trailed revenue growth of 15.5%, indicating margin pressure
- · Cash and cash equivalents declined to $1,029.9M from $1,094.9M at March 31, 2026
- · Goodwill rose to $653.6M from $489.0M and intangibles to $233.4M from $78.0M, alongside $50.0M acquisition-related deferred stock consideration, indicating acquisitions
- · Company repurchased 1,801,758 shares for $162.1M during the period
- · Section 45X credit receivable stood at $359.7M as of October 2, 2026
- · Effective tax rate rose to 23.1% in Q2 FY2027 from 19.6% a year earlier
- · Total stockholders' equity increased to $2,645.8M from $2,334.4M at March 31, 2026
02-11-2026
i-80 Gold Corp. reported Q3 2026 revenue of $32.7M, essentially flat (+2.2% YoY) versus $32.0M in Q3 2025, while gross profit improved to $5.0M from $3.1M. However, the net loss widened to $48.4M (-$0.06/share) from $41.9M (-$0.05/share) as pre-development, evaluation and exploration spending jumped 66% to $33.4M and interest expense rose to $9.1M. For the nine months, revenue grew 48% to $109.5M but the net loss ballooned to $179.5M from $113.3M, with cash used in operations deepening to $127.2M from $49.3M.
- · Cash and cash equivalents surged to $411.4M at September 30, 2026 from $63.2M at December 31, 2025, funded by $287.5M of 2026 Convertible Debentures, $225.0M NSR Royalty and $150.0M 2026 Gold Prepay proceeds.
- · Total liabilities more than doubled to $931.1M from $356.6M, with non-current debt rising to $452.2M from $97.9M, while total equity fell to $224.6M from $346.8M.
- · Nine-month 2026 cash used in operating activities deepened to $127.2M from $49.3M, and capital additions rose to $56.8M from $4.7M.
- · Accumulated deficit widened to $663.1M from $483.7M at year-end 2025.
- · Q3 2026 basic and diluted net loss per share was $0.06 versus $0.05 a year earlier; nine-month loss per share was $0.21 versus $0.18.
- · Nine-month 2026 other expenses were $80.4M versus $28.1M in 2025, and a $7.1M loss on loan extinguishment was recorded.
- · Construction-in-progress rose to $103.5M from $34.4M, and inventories increased to $41.4M from $29.3M.
02-11-2026
Sinda Ltd. reported a Q3 2026 net loss of $14.9M, a roughly 5.4x widening from the $2.8M loss in Q3 2025, as exploration expenses surged to $10.1M from $1.3M and G&A jumped to $6.9M from $1.4M. Nine-month net loss widened to $43.1M from $7.5M, with operating cash burn of $33.2M versus $7.7M a year earlier. The balance sheet was transformed by $328.3M in share issuance proceeds, lifting cash to $305.6M from $10.8M and total stockholders' equity to $311.5M from $20.3M, while interest income of $2.2M partially offset the losses.
- · Foreign exchange loss widened to $97,058 for nine months 2026 from $40,478 in 2025
- · Interest expense with related parties was $0 in 2026 versus $265,632 in 2025
- · Share-based compensation rose to $9,888,964 for nine months 2026 from $1,068,312 a year earlier
- · VAT receivable gross balance rose to $12,273,416 from $8,790,906, with allowance for uncollectible VAT increased by $598,888 provision
- · Accounts payable increased to $9,414,191 from $2,079,887 at year-end 2025
- · Capital expenditures (additions to PP&E) were $320,048 versus $31,665 prior year
- · No income tax expense recorded in either period
- · Accumulated deficit deepened to $164,379,314 from $121,253,299 at December 31, 2025
- · Shares outstanding grew from 128,136,859 to 158,790,885 through multiple issuances during 2026
02-11-2026
Seaport Therapeutics filed its first 10-Q as a public company, reporting Q3 2026 net loss of $26.4M versus $22.5M in Q3 2025, while nine-month net loss widened sharply to $114.4M from $50.7M. The company completed its IPO in Q2 2026, converting all preferred stock and raising $239.2M net, boosting total stockholders' equity to $397.5M from a $92.5M deficit at year-end 2025. However, operating expenses surged — nine-month G&A jumped to $53.8M from $15.7M (including $39.1M of stock-based comp) and R&D rose to $69.9M from $44.4M — driving cash used in operations to $69.0M from $51.3M.
- · Net loss per share improved to $(0.49) in Q3 2026 from $(9.43) in Q3 2025 due to the much larger post-IPO share count (53,530,550 vs 2,389,888 weighted-average shares)
- · All Series A-1, A-2 and B convertible preferred stock (113,921,036 shares) converted to 36,272,475 common shares upon IPO closing
- · Nine-month stock-based compensation expense rose to $41.9M from $5.2M in the prior year
- · Accumulated deficit deepened to $228.5M from $114.1M at December 31, 2025
- · Total liabilities increased to $20.2M from $16.2M at year-end 2025
- · Nine-month 2026 investing activities used $155.5M net, versus $211.9M in 2025
- · Income tax provision rose to $0.9M for nine months 2026 from $0.3M in 2025
- · Unrealized loss on available-for-sale securities of $2.0M in nine months 2026 versus a $0.2M gain in 2025
02-11-2026
Tempus AI reported Q3 2026 total net revenue of $411.5M, up 23.1% YoY from $334.2M, with Diagnostics revenue rising 20.0% to $303.5M and Data and applications growing 32.9% to $108.1M. Net loss narrowed sharply to $14.9M from $79.98M a year ago, aided by $47.1M of other income, but the nine-month operating loss widened to $217.5M from $191.5M as total costs rose 24.0% and SG&A jumped 23.4%. Cash and equivalents declined to $590.5M from $604.8M at year-end 2025, with $71.6M used in operations over nine months.
- · Net loss per share improved to $(0.08) in Q3 2026 from $(0.46) in Q3 2025; nine-month loss per share was $(0.75) vs $(1.10)
- · Nine-month Diagnostics revenue rose to $853.9M from $688.5M, while Data and applications rose to $288.2M from $216.1M
- · Cost of revenues, diagnostics increased to $114.0M from $98.6M; data and applications cost rose to $30.8M from $25.6M
- · Technology research and development expense rose to $45.7M from $38.1M; R&D rose to $46.0M from $45.0M
- · Interest expense fell to $6.7M from $15.4M in Q3, and to $31.3M from $55.0M over nine months
- · Nine-month 2025 included a $45.7M income tax benefit; 2026 had a $0.3M provision
- · Losses from equity method investments were $8.3M over nine months 2026 vs $2.5M in 2025
- · Convertible senior notes, net rose to $1.17B from $728.1M; $443.1M in proceeds raised net of discount in 2026
- · Long-term debt and the $100.0M revolving credit facility were fully repaid during 2026
- · Total assets grew to $2.45B from $2.27B; total liabilities rose to $1.95B from $1.78B
- · Accumulated deficit widened to $2.53B from $2.40B
- · Nine-month 2026 investing outflow was $38.7M vs $387.6M in 2025, which included $375.0M of business combinations
- · Stock-based compensation nearly doubled to $154.9M from $79.4M over nine months
- · Marketable equity securities totaled $259.2M ($46.9M current + $212.3M non-current) at September 30, 2026
02-11-2026
Krystal Biotech reported Q3 2026 product revenue of $127.3M, up 30.2% YoY from $97.8M, driven by international expansion (Europe $23.3M vs $4.9M; Japan $8.8M vs nil) while US revenue was roughly flat at $95.3M (+2.6% YoY). Net income fell 20.5% YoY to $63.1M as a $17.1M income tax expense replaced a $31.4M tax benefit, though operating income rose 72% to $71.1M; nine-month revenue grew 28.7% to $362.9M with net income up 13.3% to $173.8M.
- · Q3 2026 R&D expense $14.9M vs $14.6M in Q3 2025 (+2.1%)
- · Nine-month 2026 SG&A rose to $114.6M from $105.3M (+8.9%)
- · Nine-month 2026 cost of goods sold $20.3M vs $16.5M (+23.5%)
- · Interest and other income, net rose to $9.0M in Q3 2026 from $6.6M
- · Cash and cash equivalents declined to $462.8M from $496.3M at Dec 31, 2025, while total investments rose to $731.3M from $459.6M
- · Net cash provided by operating activities was $246.4M for 9M 2026 vs $123.4M in 9M 2025
- · Customer A represented 61% of accounts receivable at September 30, 2026 (66% at Dec 31, 2025); Customer B fell below 10% (was 14%)
- · Accrued rebates rose to $94.2M from $58.2M at year-end 2025
- · Income taxes paid were $22.7M in 9M 2026 vs $13.9M in 9M 2025
- · Total stockholders' equity increased to $1.436B from $1.220B at Dec 31, 2025
02-11-2026
Boardwalk Pipeline Partners reported Q3 2026 total operating revenues of $613.6M, up 13.4% YoY from $540.9M, driven by transportation (+8.9%) and product sales (+33.5%). However, operating income fell 8.4% YoY to $147.9M and net income declined 9.1% YoY to $115.3M, as total operating costs and expenses rose 22.7% (including a $8.8M loss on sale of assets/impairments vs $0.2M prior year). For the nine-month period, revenue grew 6.8% to $1,809.0M while net income rose 1.5% to $461.1M, with operating income essentially flat (-0.1%).
02-11-2026
Marriott reported Q3 2026 net income of $794M, up 9.1% YoY from $728M, on total revenues of $7,005M (+8.0% YoY). Diluted EPS rose 13.9% to $3.04, driven by strong franchise fee growth (+15.0% to $1,007M) and incentive management fees (+22.3% to $181M). However, interest expense climbed 10.2% to $227M, other comprehensive income swung to a $8M loss, and share count fell to 260.6M basic shares from 271.8M due to $3,081M in YTD buybacks.
- · Nine-month net income grew only 2.4% YoY to $2,208M, a sharp deceleration versus Q3's 9.1% growth, reflecting a higher tax provision ($754M vs $656M).
- · Nine-month other comprehensive income swung to a $51M loss from $390M income, driven by foreign currency translation adjustments of -$60M vs +$414M prior year.
- · Long-term debt rose 9.6% to $16,434M from $14,995M at year-end 2025, while current portion of long-term debt fell to $409M from $1,209M.
- · Stockholders' deficit widened to $5,084M from $3,771M, driven by $3,081M in YTD treasury stock purchases.
- · Restructuring and merger-related recoveries were nil in Q3 2026 versus a $40M benefit in Q3 2025, a headwind to operating income comparison.
- · Owned, leased, and other expense rose 12.9% YoY to $395M in Q3, outpacing owned/leased revenue growth of 3.8% to $436M.
- · Net cash from operating activities rose 35.9% to $3,239M for nine months 2026.
02-11-2026
Safeguard Acquisition Corp., a blank-check shell company, reported Q3 2026 net income of $1,940,114 versus a net loss of $58,650 in the prior-year period, driven entirely by $2,170,315 of interest earned on its $236,834,020 Trust Account. Operating losses widened sharply to $230,201 in Q3 2026 from $58,650 a year earlier as third-party costs rose to $117,701 and related-party costs of $112,500 were incurred, while cash declined to $938,218 from $1,634,631 at year-end 2025. For the nine months, net income was $5,569,243, but accumulated deficit deepened to $8,267,521 from $7,528,940 due to $6,307,824 of remeasurement charges on redeemable Class A shares.
- · Class A shares subject to possible redemption carried at ~$10.30 per share as of September 30, 2026 vs ~$10.02 at December 31, 2025
- · Basic and diluted net income per Class A share was $0.06 in Q3 2026 and $0.18 for nine months 2026, versus $0.00 and $0.00 in prior-year periods
- · Class B per-share net income was $0.06 in Q3 2026 vs a loss of $0.01 in Q3 2025
- · Nine-month 2026 related-party operating costs totaled $362,500 versus none in the prior-year period
- · Deferred underwriting fee of $9,200,000 remained unchanged
- · Total assets grew to $237,878,137 from $232,307,042 at December 31, 2025
- · Company is a shell company / emerging growth company / non-accelerated filer incorporated in Nevada (E9), CIK 0002082844
- · Warrants exercisable at $11.50 per share; 5,000,000 preference shares authorized with none issued
- · No legal proceedings, defaults, or unregistered equity sales reported in Part II
02-11-2026
Loews Corp reported Q3 2026 net income attributable to Loews of $306M ($1.50/share), down 39% from $504M ($2.43/share) in Q3 2025, despite total revenues rising 1.9% to $4,759M from $4,671M. The decline was driven by a sharp 15.5% jump in insurance claims and policyholders' benefits to $2,347M (including a $222M re-measurement loss vs $36M prior year) and a 4.1% drop in net investment income to $713M. Nine-month net income fell 14.1% to $1,087M ($5.29/share) from $1,265M, while a large $2,077M unrealized investment loss pushed comprehensive income attributable to Loews to a loss of $636M in Q3 versus income of $845M a year ago.
- · Q3 2026 insurance re-measurement loss of $222M versus $36M in Q3 2025; nine-month re-measurement loss $266M vs $59M
- · Operating revenues and other rose 14.5% YoY to $869M in Q3 2026 from $759M
- · Nine-month 2026 net cash flow provided by operating activities fell to $1,992M from $2,662M
- · Accumulated other comprehensive loss widened to $(2,117)M from $(1,067)M at year-end 2025
- · Total investments declined to $53,511M from $55,376M at December 31, 2025
- · Short-term debt fell to $521M from $1,052M; principal payments on debt were $1,102M in 9M 2026
- · Total shareholders' equity declined to $18,304M from $18,686M at year-end 2025
- · Quarterly dividend of $0.0625 per share paid; $24M total dividends in Q3 2026
- · Nine-month 2026 treasury stock purchases of $334M vs $706M in 2025
- · Weighted average diluted shares fell to 204.57M from 207.71M YoY
02-11-2026
Alexander's Inc. reported Q3 2026 net income of $27.4M ($5.33/share), up sharply from $5.97M ($1.16/share) in Q3 2025, driven largely by a $148.0M net gain on sale of real estate recognized in the nine-month period. Q3 rental revenues rose 34.9% YoY to $72.1M, but total nine-month revenues grew only 12.7% to $180.2M while total expenses increased 4.7% to $114.6M, and nine-month operating cash flow fell 40.2% to $29.9M from $50.0M. Excluding the one-time real estate gain, nine-month net income would have been roughly $39.4M versus $24.4M prior year, with interest and other income declining 45.8% to $6.3M and G&A expenses rising 42.3% to $7.0M.
- · Net gain on sale of real estate of $148.0M drove nine-month 2026 net income; proceeds from sale were $205.8M
- · Nine-month 2026 net income excluding the real estate gain would be approximately $39.4M versus $24.4M in 2025
- · Interest and debt expense declined to $32.5M for nine months 2026 from $37.7M in 2025
- · Real estate, net decreased to $564.0M as of September 30, 2026 from $630.6M at December 31, 2025
- · Total equity rose to $227.9M from $109.2M at year-end 2025, aided by retained earnings of $187.3M
- · Lease incentive liability fell to $73.8M from $113.6M at December 31, 2025
- · Cash and cash equivalents plus restricted cash totaled $349.1M at September 30, 2026 versus $352.3M a year earlier
- · PIK interest expense of $5.8M recorded in nine-month 2026 versus none in 2025
- · Quarterly dividend of $4.50 per share paid; nine-month dividends totaled $13.50 per share ($69.4M)
- · Fees to Vornado: $4.9M operating fees and $1.9M management fees for nine months 2026
02-11-2026
Bioventus reported Q3 2026 net sales of $142.4M, up 2.7% YoY from $138.7M, while nine-month sales rose 4.3% to $427.7M. Q3 operating income declined 13.8% YoY to $9.7M and gross margin slipped to 68.2% from 68.0%, but net income attributable to Bioventus jumped 89.8% to $6.0M on sharply lower interest expense ($3.8M vs $6.2M) and a tax benefit. Nine-month net income attributable to Bioventus surged to $42.5M from $8.0M, aided by a $21.0M income tax benefit, while cash fell to $30.7M from $51.2M as the company repaid $64.5M of long-term debt.
- · Q3 2026 gross margin was 68.2% vs 68.0% in Q3 2025
- · SG&A expense rose 5.4% YoY to $82.9M in Q3 2026 from $78.7M
- · R&D expense increased to $3.4M in Q3 2026 from $2.9M
- · Diluted EPS was $0.08 in Q3 2026 vs $0.05 in Q3 2025; nine-month diluted EPS $0.60 vs $0.12
- · Total stockholders' equity rose to $291.9M at Sept 26, 2026 from $228.4M at Dec 31, 2025
- · Accumulated deficit narrowed to $292.4M from $334.9M
- · Deferred tax assets increased to $29.5M from $5.5M, tied to release of valuation allowance
- · Accounts payable rose to $25.8M from $10.9M while accrued liabilities fell to $109.0M from $130.2M
- · Nine-month 2025 included $19.8M payment of contingent consideration and debt refinancing activity
02-11-2026
Miami International Holdings reported Q3 2026 total revenues of $376.2M, up 10.7% YoY from $339.8M, driving net income of $52.5M versus a $102.1M loss in Q3 2025 (which included a $107.7M debt extinguishment loss). Nine-month net income reached $266.9M versus a $100.0M loss, aided by a $50.6M gain on sale of business and a $74.0M income tax benefit. However, total cost of revenues rose 6.5% in Q3 to $245.2M, liquidity payments remained the largest cost at $206.3M (down 5.0% YoY), and nine-month operating expenses climbed 9.0% to $279.7M including a $30.0M litigation settlement, while compensation and benefits fell 41.4% in Q3 to $40.3M.
- · Section 31 fees were $23.0M in Q3 2026 versus $0 in Q3 2025, and $46.0M for nine months 2026 versus $35.2M in 2025
- · Nine-month 2026 operating expenses of $279.7M included a $30.0M litigation settlement and $5.4M marketing/business development (up from $2.1M)
- · Nine-month 2026 net cash from operations was $206.7M versus $120.8M in 2025
- · Cash, cash equivalents, segregated cash and restricted cash totaled $832.4M at September 30, 2026 versus $524.4M a year earlier
- · Nine-month 2026 investing activities provided $18.9M, including $59.9M proceeds from sale of business, versus $84.5M used in 2025
- · Nine-month 2026 financing activities provided $49.5M versus $211.7M in 2025 (which included $369.0M IPO proceeds)
- · Share-based compensation expense fell to $23.5M for nine months 2026 from $48.0M in 2025
- · Accumulated deficit narrowed to $365.4M at September 30, 2026 from $632.3M at December 31, 2025
- · Deferred tax asset of $63.8M recognized at September 30, 2026 versus none at year-end 2025
- · Total stockholders' equity rose to $1.22B from $881.0M at December 31, 2025
02-11-2026
Calor Del Sol Inc. filed its 10-Q for the quarter ended July 31, 2026, reporting zero revenue for both the current and prior-year periods. Net loss widened to $11,801 from $11,338 a year earlier (+4.1%), driven by higher general and administrative expenses of $11,801 versus $11,338. The company remains pre-revenue with an accumulated deficit of $81,608 and total stockholder's deficit of $77,608, funded entirely by related-party advances of $10,775 during the quarter.
- · Cash balance of $150 at July 31, 2026 versus $0 at April 30, 2026; prior-year quarter ended with negative cash of $(89).
- · Accounts payable rose to $6,083 from $4,907 at fiscal year-end.
- · Due to related party increased to $71,675 from $60,900, now the largest liability.
- · Net loss per share was $(0.00) basic and diluted in both periods.
- · Weighted average shares outstanding remained flat at 4,000,000.
- · No investing activities and no interest or income taxes paid in either period.
- · Company has no revenue and relies on related-party financing to fund operations.
02-11-2026
Choice Hotels reported Q3 2026 total revenues of $458.3M, up 2.5% YoY from $447.3M, with franchise and management fees rising 5.1% to $203.7M. However, net income plunged 67.8% to $57.9M (EPS $1.28 vs $3.86) largely because the prior-year quarter included a $100.0M gain from a joint venture acquisition, and Q3 2026 absorbed $24.3M in contract termination costs plus a $6.0M long-lived asset impairment; operating income fell 25.2% to $106.5M. Nine-month revenue grew 2.7% to $1,239.7M while net income dropped 53.5% to $142.6M, and other revenue declined 30.7% YoY in Q3 to $15.3M.
- · Selling, general and administrative expense rose 2.1% YoY to $81.3M in Q3 2026
- · Reimbursable expenses from franchised and managed properties rose 4.6% YoY to $192.8M in Q3 2026
- · Interest expense increased 8.9% YoY to $25.6M in Q3 2026
- · Equity in net loss of affiliates was $6.9M in Q3 2026 vs $10.9M in Q3 2025
- · Nine-month contract liability (deferred revenue) balance rose to $236.5M from $220.3M at Dec 31, 2025
- · Franchise agreement acquisition costs, net of reimbursements, were $104.0M for nine months 2026 vs $62.4M in 2025
- · Cash dividends declared per share held flat at $0.2875 quarterly ($0.8625 nine-month)
- · Treasury stock purchases increased to $166.2M for nine months 2026 from $113.0M in 2025
- · Revolving credit facility balance reduced to $239.9M from $469.8M at Dec 31, 2025, while a new $500M 2026 Term Loan was drawn
- · Accounts receivable allowance for credit losses rose to $82.6M from $51.2M at Dec 31, 2025
02-11-2026
Estée Lauder reported Q1 FY2027 net sales of $3,715M, up 6.7% YoY from $3,481M, with operating income more than doubling to $408M from $169M and net earnings jumping to $233M from $47M (diluted EPS $0.64 vs $0.13). However, gross margin pressure persisted as cost of sales fell only 2.7% while SG&A rose 3.0% to $2,365M, and the company burned $166M in operating cash flow (improved from -$340M) as accounts receivable swelled $399M and inventory rose $146M. Cash declined $300M to $3,198M and total debt remained elevated at $7,251M, while restructuring charges fell to $40M from $89M.
- · Gross margin improved to 75.7% of net sales from 73.4% YoY
- · Interest expense declined to $83M from $86M YoY
- · Effective tax rate rose to 32.5% from 56.9% YoY
- · Accounts receivable rose $399M in the quarter, a larger build than the $358M prior year
- · Inventory increased $146M versus a $6M decrease in the prior-year quarter
- · Accrued restructuring balance fell to $432M from $531M at June 30, 2026
- · Total debt stands at $7,251M ($503M current + $6,748M long-term)
- · Depreciation and amortization declined to $191M from $200M
- · Cash flow from investing used $61M vs $116M prior year; capex $69M vs $96M
- · No deferred consideration payment in Q1 FY2027 vs $150M paid prior year
02-11-2026
Information Services Group reported Q3 2026 revenue of $65,105 thousand, up 4.4% YoY from $62,364 thousand, with operating income rising 40.6% to $6,450 thousand and net income up 10.3% to $3,370 thousand. Nine-month revenue grew 4.5% to $191,776 thousand and net income jumped 39.5% to $9,384 thousand, however operating cash flow declined sharply to $16,791 thousand from $23,950 thousand and SG&A costs rose 7.3% over the nine months, while comprehensive income fell slightly YoY due to foreign currency translation losses.
- · Provisions for credit losses surged to $4,394 thousand in 9M 2026 from $129 thousand in 9M 2025
- · Accounts receivable allowance fell to $223 thousand from $2,359 thousand at year-end 2025
- · Income tax provision rose to $6,028 thousand in 9M 2026 from $3,430 thousand, raising effective tax rate
- · Cash paid for taxes increased to $4,107 thousand from $904 thousand YoY
- · Accumulated deficit narrowed to $81,139 thousand from $90,523 thousand at December 31, 2025
- · Quarterly dividend of $0.045 per share paid; $0.135 per share for nine months
- · Treasury shares repurchased $8,001 thousand in 9M 2026 vs $7,279 thousand in 9M 2025
- · Goodwill declined to $89,062 thousand from $89,375 thousand; intangible assets fell to $2,572 thousand from $3,305 thousand
- · Contingent consideration liability rose to $350 thousand from $334 thousand
- · Prior-year period included $720 thousand gain on sale of business and $1,636 thousand Martino & Partners acquisition
02-11-2026
Entergy Texas filed its Q3 2026 10-Q reporting consolidated net income attributable to Entergy Corporation of $940.3 million for the quarter versus $693.8 million in 2025, and $1,807.8 million for the nine-month period versus $1,522.5 million. Operating revenues rose to $4,353 million from $3,797 million, driven by retail electric price (+$206M), volume/weather (+$196M), and return on construction work in progress (+$52M), partially offset by a $15 million purchased power agreement termination proceeds item. However, sales for resale declined 14% YoY to 3,528 GWh and governmental sales slipped 1%, while Parent & Other net loss widened to $139.1 million for the quarter from $116.7 million.
- · Parent & Other net loss widened to $139.1M in Q3 2026 from $116.7M in Q3 2025, and to $437.2M for nine months 2026 from $376.5M
- · Sales for resale fell 14% YoY to 3,528 GWh from 4,079 GWh
- · Governmental sales declined 1% YoY to 673 GWh from 678 GWh
- · Nine-month 2026 operating revenues were $1,088.7M at the Utility segment versus $1,094.0M prior year
- · Q3 2026 interest expense was $110.7M (Utility $77.6M, Parent & Other $33.0M)
- · Q3 2026 income taxes were $73.4M versus prior-year comparative
- · Asset write-offs, impairments, and related charges were $12.8M in Q3 2026
- · Nine-month 2026 asset write-offs, impairments, and related charges totaled $5.3M
02-11-2026
First Bancorp reported Q3 2026 net income of $51.3M ($1.24 diluted EPS), up 152% from $20.4M ($0.49) in Q3 2025, though the prior-year quarter was depressed by a $27.9M securities loss. Net interest income rose 12% YoY to $114.8M and the provision for credit losses fell to $1.3M from $3.4M. However, noninterest income dropped to $15.1M from $15.1M excluding the prior-year loss (other service charges fell 13% to $5.5M), noninterest expense rose 6.3% to $64.0M, and a $45.6M other comprehensive loss on the securities portfolio drove comprehensive income down to just $5.7M from $56.5M a year earlier.
- · Other service charges, commissions and fees fell 13% YoY to $5.5M in Q3 2026 from $6.3M
- · Salaries expense rose 5.1% YoY to $32.7M and employee benefits jumped 18.4% to $6.8M
- · Nine-month 2026 net income rose 55.7% to $148.5M from $95.3M
- · Securities available for sale fair value of $1.99B vs amortized cost of $2.25B, implying unrealized losses of ~$264M
- · Securities held to maturity fair value of $407.9M vs amortized cost of $508.1M
- · Net loans grew to $9.10B from $8.72B at year-end 2025
- · Noninterest-bearing deposits rose to $3.63B from $3.49B at December 31, 2025
- · Nine-month 2026 net cash provided by operating activities was $229.2M vs $148.0M in 2025
- · Company repurchased $7.3M of common stock in 9M 2026 vs $1.0M in 9M 2025
- · Merger and acquisition expenses of $0.45M recorded in Q3 2026 (none in prior year)
02-11-2026
Vitesse Energy reported Q3 2026 total revenue of $82.95M, up 23% YoY from $67.44M, driven by a 19% increase in oil revenue to $76.52M and a 113% surge in natural gas revenue to $6.44M. However, a $58.59M commodity derivative loss swung total other expense to $61.84M, resulting in a net loss of $36.36M (-$0.86 per share) compared to a net loss of $1.31M (-$0.03) in Q3 2025. For the nine months, revenue rose 12% to $241.37M but net income turned to a loss of $45.56M from a profit of $26.02M, primarily due to a $91.55M derivative loss versus a $18.96M gain last year.
- · Total assets increased to $933.33M at September 30, 2026 from $893.35M at December 31, 2025.
- · Revolving credit facility outstanding rose to $190.50M from $124.50M at year-end 2025.
- · Cash decreased to $0.65M from $1.33M at December 31, 2025.
- · Net cash provided by operating activities for the nine months ended September 30, 2026 was $88.84M, down from $132.91M in the prior-year period.
- · Dividends paid during the nine months were $62.71M, down from $69.84M in the prior-year period.
- · Common stock dividends declared were $0.4375 per share in 2026 versus $0.5625 per share in 2025.
- · Weighted average diluted shares outstanding for Q3 2026 were 42,258,562, up from 39,135,284 in Q3 2025.
- · Accumulated deficit was $47.61M at September 30, 2026, compared to $2.05M at December 31, 2025.
- · Total equity decreased to $570.94M from $629.32M at December 31, 2025.
- · During Q2 2026, the company issued 1,935,698 shares for the Powder River Basin Acquisition, valued at $36.45M net of issuance costs.
- · In 2025, the company issued 8,169,839 shares to acquire Lucero, valued at $194.28M.
- · Proved oil and gas properties increased to $1,661.85M from $1,525.89M at December 31, 2025.
- · Commodity derivative liabilities totaled $40.30M at September 30, 2026, versus $14.48M in assets at December 31, 2025.
02-11-2026
First Hawaiian reported Q3 2026 net income of $63.7M, down 13.7% YoY from $73.8M, as EPS fell to $0.52 from $0.59. Net interest income rose 2.8% YoY to $174.1M on lower interest expense, but the provision for credit losses jumped to $20.3M from $4.5M and noninterest expense surged 27.3% to $160.0M (including $6.7M merger-related costs and a spike in other expense to $39.4M), driving the earnings decline. Nine-month net income was roughly flat at $204.9M versus $206.3M, while total comprehensive income collapsed to $19.7M from $92.7M on a $44.0M other comprehensive loss tied to investment securities.
- · Total interest income fell 3.3% YoY to $234.5M in Q3 2026 from $242.6M, with loan and lease interest income down to $192.4M from $196.4M.
- · Interest expense declined 17.5% YoY to $60.4M from $73.2M, driven by lower deposit costs ($60.2M vs $70.9M).
- · Nine-month noninterest expense rose 11.8% to $418.4M from $374.2M, including $10.9M of merger-related costs.
- · Accumulated other comprehensive loss widened to $403.8M at Sep 30, 2026 from $368.1M at Dec 31, 2025.
- · Allowance for credit losses declined to $164.4M from $168.5M at year-end 2025.
- · Noninterest-bearing deposits fell to $6.40B from $6.55B at Dec 31, 2025.
- · Q3 2026 effective tax benefit of $13.9M versus a $22.3M provision in Q3 2025.
- · Quarterly dividend of $0.26 per share declared; nine-month dividends $0.78 per share.
- · Share count declined via $32.0M of buybacks in nine months 2026 (1,307,738 shares).
02-11-2026
Backblaze reported Q3 2026 revenue of $46.654M, up 25.5% YoY from $37.162M, and narrowed its quarterly net loss to $2.364M from $3.778M, with gross profit rising 29.3% to $29.838M. However, total operating expenses grew 17.6% to $31.248M (G&A +44.3%, S&M +19.4%) and interest expense more than doubled to $1.981M, while nine-month revenue of $128.033M (+18.5%) still produced a $13.600M net loss. The balance sheet transformed after a $201.250M convertible senior notes issuance, lifting cash to $189.018M and total assets to $427.592M, but adding $194.485M of long-term debt and $346.299M in total liabilities versus $108.605M at year-end 2025.
- · Gross margin improved to 64.0% in Q3 2026 from 62.1% in Q3 2025
- · Nine-month gross profit rose 22.7% to $80.201M from $65.368M
- · Nine-month R&D expense declined 3.8% to $33.634M from $34.968M
- · Nine-month S&M rose 9.9% to $31.238M and G&A rose 28.2% to $26.266M
- · Net loss per share improved to $(0.04) from $(0.07) in Q3 and to $(0.22) from $(0.36) for nine months
- · Weighted average diluted shares rose to 62,536,342 from 56,977,764
- · Accumulated deficit widened to $235.197M from $221.597M at year-end 2025
- · Total stockholders' equity slipped to $81.293M from $83.221M at Dec 31, 2025
- · Nine-month investing outflow was $31.205M, including $7.906M capitalized software and $38.694M securities purchases
- · Debt issuance costs paid were $6.512M in 2026 versus $0.602M in 2025
- · Treasury stock purchases totaled $1.375M in 2026 and $1.185M in 2025
- · Deferred revenue, current declined to $29.755M from $30.498M at year-end 2025
02-11-2026
V2X reported Q3 2026 revenue of $1,271.5M, up 8.9% YoY from $1,167.1M, driven by a 30.6% surge in United States revenue and explosive time-and-materials growth (+470%). However, Middle East revenue fell 30.2% YoY and Army revenue declined 24.8%, while firm-fixed-price revenue slipped 4.0%, producing a mixed geographic and contract-mix picture. Nine-month revenue rose 16.0% to $3,782.2M, and remaining performance obligations grew 14.7% to $3,871M, signaling a healthy backlog despite segment softness.
- · Inventory, net rose to $62.7M from $45.9M at Dec 31, 2025
- · Prepaid taxes fell to $3.2M from $9.4M at Dec 31, 2025
- · Billed receivables increased to $147.0M from $87.1M; unbilled receivables (contract assets) rose to $649.4M from $628.5M
- · Nine-month Army revenue declined 11.0% to $1,199.9M while Air Force grew 69.4% to $634.3M
- · Nine-month subcontractor revenue fell 11.8% to $158.5M
- · Europe nine-month revenue was essentially flat (+0.2%) at $149.8M
- · Contractual payments due include a $1,008.9M obligation in 2030
02-11-2026
Syndax Pharmaceuticals reported Q3 2026 total revenues of $83.3M, up 81.6% YoY from $45.9M, driven by product revenue of $60.7M (+89.8%) and collaboration revenue of $22.6M (+62.7%). Net loss narrowed to $49.4M (-$0.55/share) from $60.7M (-$0.70/share) a year ago, though operating expenses rose 21.2% to $125.2M on higher R&D (+19.9%) and cost of product sales ($14.0M vs $2.1M), while SG&A declined 2.7%. The company swung to a total stockholders' deficit of $17.2M from $64.6M equity at year-end 2025, reflecting a $250M convertible note issuance and continued losses.
- · Total stockholders' equity swung to a deficit of $17.2M at September 30, 2026 from $64.6M at December 31, 2025.
- · Accumulated deficit deepened to $1,648.0M from $1,506.6M at year-end 2025.
- · Royalty interest expense rose to $35.8M for nine months 2026 from $24.2M a year ago.
- · Interest income fell 29.9% to $12.9M for nine months 2026 from $18.4M.
- · Net cash used in operating activities improved to $107.9M from $253.5M in the prior-year period.
- · Convertible note interest expense of $1.7M recorded for nine months 2026 (none in prior year).
- · Accounts payable fell to $3.6M from $16.6M at December 31, 2025.
- · Cash paid for royalty interest financing was $23.6M vs $6.9M a year ago.
- · Stock-based compensation rose to $41.4M from $36.2M for the nine-month period.
02-11-2026
Waystar Holding Corp. reported Q3 2026 revenue of $325.6M, up 21.2% YoY, and net income of $31.0M, up 1.2% YoY. However, operating income grew only 1.7% YoY to $61.3M as operating expenses surged 26.8%, driven by higher general and administrative (+58.5%) and research and development (+63.7%) costs. Diluted EPS declined to $0.16 from $0.17 in Q3 2025.
02-11-2026
ON Semiconductor reported Q3 2026 revenue of $1,722.3M, up 11.1% YoY from $1,550.9M, with net income attributable to the company rising 23.1% to $313.9M and diluted EPS up to $0.79 from $0.63. Gross profit jumped 21.4% to $713.0M, driven by the PSG segment (revenue +20.6% YoY, gross profit +61.6%). However, the AMG segment grew revenue only 2.4% while its gross profit slipped 1.2%, and ISG revenue rose just 2.2% with gross profit down 9.0% YoY, showing mixed segment performance. Nine-month operating income swung to $583.5M from a $115.9M loss, though this was aided by sharply lower restructuring/impairment charges ($375.1M vs $608.1M).
- · Nine-month 2026 operating income was $583.5M versus a $115.9M operating loss in the prior-year period, aided by restructuring/impairment charges falling to $375.1M from $608.1M
- · Nine-month 2026 net income tax provision was $116.6M versus a $27.6M benefit in the prior-year period
- · Cash and cash equivalents rose to $4,157.7M from $2,147.6M at year-end 2025, aided by $1,473.7M of debt issuance and $281.0M warrant proceeds, offset by $351.6M bond hedge purchases
- · Total debt increased with $802.8M current portion of long-term debt and $3,660.2M long-term debt versus $2,980.5M long-term debt at year-end 2025
- · Nine-month 2026 capital expenditures fell to $84.0M from $272.1M a year earlier
- · Share repurchases slowed to $703.2M in nine-month 2026 from $927.4M in the prior-year period; treasury shares rose to 238,001,586
- · Weighted-average diluted shares fell to 397.3M in Q3 2026 from 408.0M in Q3 2025
- · Nine-month 2026 non-cash asset impairment charges were $166.6M versus $487.9M in the prior-year period
- · Interest expense declined to $13.9M in Q3 2026 from $17.7M, while interest income fell to $17.3M from $22.7M
02-11-2026
BRC Inc. reported Q3 2026 net revenue of $108.0M, up 7.3% YoY from $100.7M, and narrowed its nine-month net loss to $8.8M from $23.6M. However, the company swung to a Q3 operating loss of $7.5M from operating income of $0.5M a year earlier, driven by a $9.3M other operating expense (including an $11.7M asset impairment) and higher marketing and salary costs, pushing Q3 net loss to $8.7M from $1.2M.
- · Q3 2026 other operating expense jumped to $9.3M from $0.6M, including an $11.7M loss on impairment of assets recognized in the nine-month period.
- · Nine-month 2026 operating loss narrowed to $5.1M from $17.5M in 2025.
- · Nine-month 2026 net cash provided by operating activities was $10.4M versus cash used of $1.1M in 2025.
- · Total assets fell to $179.4M from $209.2M at year-end 2025, partly reflecting $17.1M of assets held for sale.
- · Total debt, net declined to $31.4M from $34.7M; Term Loan Facility principal is $34.9M.
- · Nine-month 2026 interest expense fell to $3.6M from $5.9M.
- · Weighted-average Class A shares rose to 11,986,604 in Q3 2026 from 10,799,479 in Q3 2025.
- · Nine-month 2026 general and administrative expense fell to $32.0M from $39.0M.
02-11-2026
First Interstate BancSystem reported Q3 2026 net income of $62.2M, down 12.9% YoY from $71.4M, with diluted EPS falling to $0.65 from $0.69, as net interest income was essentially flat at $206.2M and a $10.5M credit loss provision (versus none a year ago) weighed on results. Nine-month net income rose 6.7% to $206.3M and diluted EPS climbed to $2.13 from $1.87, helped by a $19.5M net gain on branch sales, while total assets declined 3.3% to $25,769.6M and loans held for investment fell 8.0% to $13,985.4M. However, accumulated other comprehensive loss widened to $(314.1)M from $(178.1)M, driving a Q3 comprehensive loss of $(48.4)M versus comprehensive income of $100.2M a year earlier, and deposits declined 3.2% to $21,388.5M.
- · Q3 2026 provision for credit losses was $10.5M versus $0 in Q3 2025; nine-month provision fell to $14.0M from $19.7M
- · Q3 2026 interest and fees on loans fell 13.9% YoY to $201.3M from $233.8M
- · Q3 2026 total interest income declined 6.7% YoY to $272.5M while total interest expense fell 22.2% to $66.3M
- · Nine-month 2026 noninterest income rose 15.2% to $146.1M, including a $19.5M net gain on sale of branches
- · Nine-month 2026 outsourced technology services expense rose 12.1% to $49.3M from $42.4M
- · Nine-month 2026 FDIC insurance premiums fell 21.7% to $9.4M from $12.0M
- · Noninterest bearing deposits grew to $5,446.4M from $5,286.8M, while interest bearing deposits fell to $15,942.1M from $16,801.5M
- · Allowance for credit losses declined to $181.4M from $191.4M at year-end 2025
- · Nine-month 2026 net cash distributed in sale of branches was $156.0M
- · Company repurchased 6,456,505 common shares for $234.4M in nine months 2026, versus 952,074 shares for $30.7M in the prior-year period
- · Quarterly dividend declared of $0.47 per share ($45.2M) in Q3 2026, down from $49.1M in Q3 2025 due to lower share count
- · Cash and cash equivalents declined to $1,252.6M from $1,309.7M at year-end 2025
02-11-2026
Roku reported Q3 2026 total net revenue of $1,502.0M, up 24.1% YoY from $1,210.6M, driven by Platform revenue growth of 22.9% (Advertising +23.0%, Subscriptions +22.7%). Net income surged to $183.3M ($1.20 diluted EPS) from $24.8M, and operating income turned positive at $164.1M versus $9.5M. However, Devices segment gross loss widened to $(48.6)M from $(22.9)M as device cost of revenue jumped 43.5%, and sales & marketing fell 21.2% YoY, contributing to the profit improvement.
- · Devices segment gross loss widened to $(48.6)M in Q3 2026 from $(22.9)M, with device cost of revenue up 43.5% YoY to $242.3M.
- · Research and development expense was essentially flat, up 2.5% YoY to $186.9M.
- · General and administrative expense rose 17.1% YoY to $106.7M.
- · Nine-month 2026 net cash provided by operating activities was $703.2M vs $376.1M in 2025.
- · Cash and cash equivalents rose to $2,518.8M from $1,587.1M at year-end 2025.
- · Nine-month 2026 stock-based compensation was $233.3M, down from $268.2M.
- · Company repurchased $162.7M of common stock in nine months 2026 vs $50.0M in 2025.
- · Accumulated deficit narrowed to $(1,218.0)M from $(1,488.6)M at December 31, 2025.
- · Diluted EPS was $1.20 for Q3 2026 vs $0.16 in Q3 2025.
02-11-2026
Vornado Realty L.P. reported Q3 2026 total revenues of $467.657M, up 3.1% YoY from $453.700M, driven by a 5.3% increase in rental revenues to $409.621M, while fee and other income fell 10.2% to $58.036M. However, the company swung to a net loss of $45.964M from net income of $19.239M a year earlier, and net loss attributable to common shareholders was $47.138M (-$0.25 per share) versus income of $11.589M ($0.06 per share), as depreciation and amortization jumped 44.3% to $169.045M and interest and other investment income dropped 77.2%. For the nine months, net loss attributable to common shareholders was $53.546M (-$0.28 per share) versus income of $842.250M in 2025, which had included an $803.248M gain on sales-type lease and $24.039M of disposition gains that did not recur.
- · Cash and cash equivalents fell to $580.496M from $840.850M at December 31, 2025, a decline of $260.354M.
- · Unsecured revolving credit facilities outstanding rose to $918.000M from $720.420M at year-end 2025.
- · Nine months 2026 income from partially owned entities declined 26.7% to $99.335M from $135.588M.
- · The company repurchased 4,533 thousand common shares for $133.396M during the nine months ended September 30, 2026.
- · Nine months 2026 included a $32.073M gain on debt extinguishment, partially offsetting the loss.
- · Development costs and construction in progress increased to $1.038B from $890.143M at December 31, 2025.
- · Total shareholders' equity declined to $5.846B from $5.987B at December 31, 2025.
- · Nine months 2025 results included an $803.248M gain on sales-type lease and $24.039M of net disposition gains that did not recur in 2026.
- · Diluted weighted average shares for nine months 2026 were 187,909 thousand versus 201,098 thousand a year earlier.
02-11-2026
W. R. Berkley reported Q3 2026 net income to common stockholders of $446.0M, down 12.7% YoY from $511.0M, with diluted EPS falling to $1.14 from $1.28, as total revenues were roughly flat at $3.74B versus $3.77B. Net premiums written grew 1.3% YoY to $3.27B and net investment income rose 9.2% to $383.5M, however the quarter swung to $18.3M of net investment losses from $79.0M of gains a year earlier, driving a comprehensive loss of $162.6M versus $577.3M of comprehensive income. For the nine-month period, net income rose 6.3% to $1.41B and diluted EPS improved to $3.60 from $3.32, but operating cash flow declined to $2.20B from $2.59B and treasury share repurchases surged to $435.1M from $73.8M.
- · Losses and loss expenses rose to $1,998.5M in Q3 2026 from $1,968.9M, while other operating costs and expenses increased to $1,009.6M from $975.3M.
- · Nine-month 2026 net investment losses were $89.3M versus $126.3M of gains in 2025, a swing of roughly $215.6M.
- · Accumulated other comprehensive loss widened to $1,248.7M at September 30, 2026 from $506.2M a year earlier, driven by unrealized investment losses of $928.2M.
- · Cash and cash equivalents fell to $2,113.0M at September 30, 2026 from $2,539.9M at the start of the year, a net decline of $426.9M.
- · Quarterly dividend per share rose to $0.10 from $0.09; nine-month dividends were $0.79 versus $0.76 per share.
- · Nine-month 2026 net cash used in investing activities was $1,861.9M versus $1,786.3M in 2025.
- · Diluted weighted-average shares declined to 391.3M in Q3 2026 from 400.2M a year earlier, reflecting heavier buybacks.
02-11-2026
UMH Properties reported Q3 2026 total income of $74.1M, up 10.8% YoY from $66.9M, driven by rental and related income rising 7.9% to $62.4M and manufactured home sales up 28.8% to $11.8M. However, net income fell 66.6% YoY to $3.1M and the company swung to a net loss attributable to common shareholders of $2.1M (-$0.02/share) versus $4.2M ($0.05/share) a year ago, pressured by a $3.6M fair-value decline in marketable securities and interest expense up 17.3% to $9.3M. For the nine months, total income rose 8.6% to $211.6M while net income attributable to common shareholders declined 25.0% to $4.9M.
- · Community operating expenses rose 4.7% YoY to $26.2M in Q3 2026, outpacing the 7.9% rental income growth on a margin basis.
- · Cost of sales of manufactured homes jumped 40.2% YoY to $8.1M, exceeding the 28.8% sales growth, compressing manufactured home margins.
- · General and administrative expenses rose 24.9% YoY to $5.4M in Q3 2026.
- · Depreciation expense increased 10.2% YoY to $18.5M in Q3 2026.
- · Total loans payable surged to $130.3M at 9/30/26 from $28.5M at 12/31/25, driven by $100M drawn on the unsecured line of credit and $101.9M net short-term borrowings.
- · Nine-month 2026 results included a $36.5M loss on sales of marketable securities offset by a $38.7M fair-value increase.
- · Cash and cash equivalents fell to $38.2M at 9/30/26 from $72.1M at 12/31/25; total cash including restricted was $47.0M versus $80.9M.
- · No manufactured home community acquisitions occurred in 2026 versus $40.2M in purchases in 2025.
- · Land development costs rose to $81.7M from $39.9M at year-end 2025.
- · Subsequent to quarter end, the company paid off the interest-bearing portion of its floorplan inventory financing balance.
02-11-2026
SITE Centers reported Q3 2026 rental income of $4.471M, down 81.5% YoY from $24.203M, as the company continues to shrink its portfolio through asset sales; total revenues fell 68.4% to $8.562M while fee and other income rose 41.2% to $4.091M. The company posted a net loss of $5.394M (EPS -$0.10) versus a $6.158M loss a year ago, helped by a $1.852M gain on real estate disposition versus $108.401M prior year. For the nine months, net income swung to a $5.760M loss from $43.431M income, with impairment charges of $20.450M and a $19.989M gain on sale of joint venture interests; total assets shrank to $300.508M from $418.737M at year-end 2025.
- · Interest expense fell to zero in Q3 2026 from $3.941M in Q3 2025, and to zero for nine months 2026 from $14.707M, reflecting full debt repayment.
- · Interest income rose to $1.811M in Q3 2026 from $1.411M, and to $4.617M for nine months from $2.494M.
- · Other income (expense), net worsened to -$1.577M in Q3 2026 from -$831M prior year, and to -$4.348M for nine months from -$3.070M.
- · Net cash used for operating activities was $20.564M in nine months 2026 versus $28.084M provided in nine months 2025.
- · Real estate assets, net fell to $42.887M from $225.736M at December 31, 2025.
- · Real estate and other assets held for sale totaled $15.092M at September 30, 2026, with $1.211M of related liabilities held for sale.
- · Joint venture investments declined to $25.460M from $27.676M; JV accumulated equity was $122.149M with $372.083M of mortgage debt.
- · Dividends declared in Q2 2026 were $52.691M; no dividend was declared in Q3 2026.
- · Nine-month 2026 EPS was -$0.11 versus $0.80 in nine-month 2025.
- · Proceeds from disposition of joint venture were $20.713M in nine months 2026.
02-11-2026
Centerspace reported Q3 2026 revenue of $59.5M, down 16.6% YoY from $71.4M, while nine-month revenue fell 8.1% to $190.4M. Net income surged to $143.6M in Q3 (vs $65.4M) and $127.5M for nine months (vs $44.4M), driven largely by a $150.3M gain on sale of real estate, but operating cash flow declined 24.4% to $64.8M and the company incurred $5.0M in merger-related costs. Diluted EPS rose to $7.28 from $3.19, though the diluted share count fell to 16.9M from 19.8M.
- · Property owned declined to $2,266.6M at September 30, 2026 from $2,524.0M at December 31, 2025, reflecting asset sales.
- · Revolving lines of credit fully repaid to $0 from $154.9M at year-end 2025.
- · Mortgages payable fell to $513.0M from $566.7M.
- · General and administrative expenses rose 18.2% for nine months to $17.0M from $14.4M.
- · Depreciation and amortization declined to $74.7M for nine months from $83.8M.
- · Interest expense declined to $29.5M for nine months from $33.3M.
- · Common share distributions of $2.31 per share/unit for nine months; Q3 distribution $0.77 per share/unit.
- · Nine-month 2026 net proceeds from real estate sales of $315.2M vs $122.4M prior year; no acquisitions in 2026 vs $206.2M in 2025.
- · Net cash used by financing activities of $258.9M vs $74.0M provided in 2025.
02-11-2026
Herbalife reported Q3 2026 net sales of $1,350.2M, up 6.0% YoY from $1,273.7M, with net income attributable to Herbalife rising 36.1% to $58.8M and diluted EPS up 31.0% to $0.55. However, nine-month net income fell 33.9% to $94.4M (from $142.9M) due to a $94.6M loss on debt extinguishment, while the China segment declined sharply (-22.0% YoY in Q3 to $55.6M) and gross margin slipped to 77.3% from 77.7%.
- · Gross margin declined to 77.3% in Q3 2026 from 77.7% in Q3 2025
- · Selling expenses rose 5.1% YoY to $473.5M in Q3 2026
- · G&A expenses rose 4.6% YoY to $432.1M in Q3 2026
- · Effective tax rate rose to 46.4% in Q3 2026 from 42.4% in Q3 2025
- · Nine-month 2026 operating cash flow rose to $298.0M from $235.0M
- · Total shareholders' deficit improved to $(403.7)M from $(509.4)M at year-end 2025
- · Inventories declined slightly to $508.3M from $511.7M at Dec 31, 2025
- · Share repurchases of $10.2M in nine months 2026
02-11-2026
BWX Technologies reported Q3 2026 revenue of $952.972M, up 10.0% YoY from $866.286M, with net income attributable to BWXT rising 23.9% to $101.712M and diluted EPS up 24.7% to $1.11. Nine-month revenue grew 17.4% to $2,714.814M and net income rose 19.4% to $281.797M. However, gross margin compressed as cost of operations grew 7.2% in Q3 (faster than revenue), SG&A jumped 25.5% YoY, and comprehensive income fell 12.0% in Q3 and 1.6% over nine months due to a $37.152M currency translation loss versus a $13.768M gain last year.
- · Currency translation adjustments swung to a $37.152M loss over nine months 2026 versus a $13.768M gain in 2025, driving the 1.6% decline in nine-month comprehensive income.
- · Interest expense fell 63.6% YoY in Q3 to $5.108M from $14.019M, and 55.2% over nine months to $15.124M from $33.754M.
- · Other income – net declined sharply to $0.804M in Q3 2026 from $7.222M in Q3 2025.
- · Assets of business held for sale total $700.353M ($40.822M current + $659.531M non-current) with related liabilities of $45.732M, signaling a pending divestiture.
- · Accounts payable rose to $281.639M from $141.289M at year-end 2025, and advance billings on contracts increased to $428.342M from $305.285M.
- · Goodwill declined to $472.970M from $500.860M and intangible assets fell to $277.525M from $329.859M at December 31, 2025.
- · Nine-month 2026 acquisitions totaled $186.967M versus $536.000M in the prior year period.
- · Quarterly dividend of $0.27 per share declared; nine-month dividends paid were $75.183M versus $69.704M.
- · No share repurchases in 2026 versus $30.000M in the prior year period.
- · Effective tax rate was approximately 22.7% in Q3 2026 versus 23.6% in Q3 2025.
02-11-2026
IAC Inc. (reported as People Incorporated) filed its Q3 2026 10-Q showing revenue declined 3.6% YoY to $430.8M (from $447.1M) and 2.2% for the nine-month period to $1,273.4M, while operating loss narrowed sharply to $(3.0)M from $(27.2)M in Q3 on lower cost of revenue, selling/marketing and G&A. However, a massive $1,119.9M unrealized loss on the MGM Resorts investment drove a net loss from continuing operations of $(684.9)M versus $(52.7)M a year ago, and diluted loss per share widened to $(9.15) from $(0.66). Nine-month results also included a $78.3M loss on the sale of Care.com and G&A expense rose 27% to $312.6M, pushing the nine-month operating loss to $(49.2)M from $(13.6)M.
- · Nine-month 2026 net loss attributable to shareholders was $(252.5)M vs $(27.2)M in 2025
- · Nine-month 2026 operating cash flow from continuing operations was $105.6M vs $0.1M a year ago
- · Cash and cash equivalents rose to $1,318.8M from $941.3M at year-end 2025
- · Treasury stock purchases of $133.0M in 9M 2026 vs $302.4M in 9M 2025
- · Accumulated deficit widened to $(895.5)M from $(643.0)M at Dec 31, 2025
- · Total shareholders' equity declined to $4,435.9M from $4,763.8M at Dec 31, 2025
- · Nine-month 2026 included $185.1M net proceeds from sales of investments and businesses and $170.4M of related net gains
- · Q3 2026 income tax benefit of $278.4M vs $3.1M a year ago
- · Deferred income taxes fell to $94.7M from $208.6M at year-end 2025
- · Discontinued operations largely wound down: current assets fell to $27 thousand from $95.7M
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Earnings Financial Results SEC Filings
October 29, 2026
US Earnings Financial Results SEC Filings — October 29, 2026
October 28, 2026
US Earnings Financial Results SEC Filings — October 28, 2026
October 27, 2026
US Earnings Financial Results SEC Filings — October 27, 2026
October 26, 2026
US Earnings Financial Results SEC Filings — October 26, 2026
🇺🇸 More from United States
View all →November 02, 2026
US Pre-Market SEC Filings Roundup — November 02, 2026
US Pre-Market SEC Filings Roundup
November 02, 2026
US Executive Compensation Proxy SEC Filings — November 02, 2026
US Executive Compensation Proxy SEC Filings
November 02, 2026
US Corporate Board Director Changes SEC Filings — November 02, 2026
US Corporate Board Director Changes SEC Filings
November 02, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — November 02, 2026
S&P 500 Consumer Discretionary Sector SEC Filings